CERAMIC TRANSCEND ARTICULATION SYSTEM

Prosthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented

FDA Premarket Approval P030027 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the addition of an intermediate ceramic liner size (36/48g); three replacement 36mm od ceramic heads with consistent offset (-3. 5 mm, 0 mm, and +3. 5 mm); and femoral stems and acetabular shells as specified in submissions received march 8, 2006 and june 21, 2006 which have been round substantially equivalent via the 510(k) process. The device, as modified, will be marketed under the trade name ceramic lineage/ transcend articulation system and is indicated for use in primary total hip arthroplasty in skeletally mature patients with non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and traumatic arthritis.

DeviceCERAMIC TRANSCEND ARTICULATION SYSTEM
Classification NameProsthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented
Generic NameProsthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented
ApplicantMicroPort Orthopedics Inc.
Date Received2006-03-08
Decision Date2006-06-23
PMAP030027
SupplementS002
Product CodeMRA
Advisory CommitteeOrthopedic
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address MicroPort Orthopedics Inc. 5677 Airline Rd arlington, TN 38002-0000

Supplemental Filings

Supplement NumberDateSupplement Type
P030027Original Filing
S009 2016-03-11 Normal 180 Day Track No User Fee
S008 2015-12-10 30-day Notice
S007 2013-04-26 135 Review Track For 30-day Notice
S006 2013-01-22 135 Review Track For 30-day Notice
S005 2012-02-08 Normal 180 Day Track No User Fee
S004 2007-12-28 135 Review Track For 30-day Notice
S003
S002 2006-03-08 Real-time Process
S001 2006-01-30 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.